E. Keller

Moderate Hypothermia in the Treatment of Patients With Severe Middle Cerebral Artery Infarction

Stefan Schwab, S. Schwarz, Matthias Spranger et al. · Stroke · 1998 · 674 citations · Full text

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · The Lancet Neurology · 2011 · 625 citations

Placebo-controlled Phase 3, Endovascular Technique, Vascular Surgery +5

Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · Stroke · 2012 · 323 citations · Full text

The First Three Years of the Swiss Neuropaediatric Stroke Registry (SNPSR): A Population-Based Study of Incidence, Symptoms and Risk Factors

Maja Steinlin, I. Pfister, J. Pavlovic et al. · Neuropediatrics · 2005 · 190 citations

Cerebrovascular Disease, Paediatric Stroke, Neonatal Stroke +27

Middle Cerebral Artery (MCA) Susceptibility Sign at Susceptibility-based Perfusion MR Imaging: Clinical Importance and Comparison with Hyperdense MCA Sign at CT¹

Sebastian Flacke, H. P. Urbach, E. Keller et al. · Radiology · 2000 · 174 citations